InternationalUSRemember you can easily switch between MIP US and MIP International at any time

French court issues rare injunction, awards Novartis €13m

Patrick Wingrove, London


A French court has issued a preliminary injunction against Teva’s generic anti-hypertensive drug and awarded €13 million as an advance on damages

The Tribunal de Grande Instance of Paris delivered the injunction against Teva’s generic version of Exforge (valsartan/amlodipine), which has been patented by Novartis at the EPO ( EP2322174).

The court ordered Teva to pay €5.8 million ($6.8 million) to...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null

null null null

null null null

Mid Year 2018

PTAB practice in a post-SAS world

The big questions remaining after the Supreme Court’s SAS ruling include how institution rates will change, how strategy at the Board should evolve, and how district courts and the Federal Circuit will react. Michael Loney investigates



Most read articles

Supplements